Ambrisentan is a medicine used to manage high blood pressure in the lungs. Blocking signals that narrow vessels, this agent helps blood flow more smoothly through sensitive pathways.
When the pressure in the lungs’ blood vessels rises, shortness of breath and fatigue can become daily challenges. Ambrisentan belongs to the class of endothelin receptor antagonists and is used to help manage pulmonary arterial hypertension (PAH), a condition that narrows the arteries that carry blood from the heart to the lungs. By relaxing these vessels, the medication aims to improve exercise capacity and reduce symptoms. It is the active compound in Letairis and other Ambrisentan medications available in Singapore.
In Singapore, the most common brand featuring this molecule is Letairis. The drug is supplied as oral tablets that patients swallow whole, typically ranging from 5 mg to 10 mg per tablet. Generic versions contain the same ingredient and are evaluated for the same standards as the brand product, though brand names may appear on pharmacy labels. While tablets are the primary form, the ingredient is not marketed as an inhaled or injectable product.
People diagnosed with pulmonary arterial hypertension often explore therapies that target the blood vessels of the lungs. Ambrisentan is used to address PAH-related shortness of breath, reduced exercise tolerance, and fatigue. It may be prescribed for adults in WHO functional class II-IV, meaning patients who experience symptoms during ordinary activities or at rest. Occasionally, clinicians combine Ambrisentan with other PAH-focused agents to enhance overall response, but each medication’s role is assessed individually.
The drug works by blocking a specific protein called endothelin-1 that normally tightens lung arteries. By preventing endothelin-1 from binding to its receptors, Ambrisentan helps keep the vessels relaxed and reduces abnormal growth of the arterial wall. This action can lead to lower pressure in the pulmonary circulation and may improve how easily oxygen moves into the bloodstream.
Mild signs that often appear early include headache and swelling in the ankles or feet. Some people also notice facial flushing, nasal congestion, or a brief feeling of warmth after taking the tablet. These effects are usually short-lasting and may lessen as the body adjusts.
Rare but serious signals may involve sudden breathlessness, chest pain, or signs of liver trouble such as yellowing of the skin or dark urine. Unexpected fluid buildup, severe anemia, or a rapid increase in blood pressure should prompt urgent medical attention.
This medicine should be avoided in people who are pregnant, because it can affect fetal development. Individuals with severe liver disease or known hypersensitivity to Ambrisentan should also not use it. Caution is advised for patients with a history of heart failure or low blood oxygen levels.
Alcohol and certain heart medicines can change how the drug works, so reading the label is important. Drugs that strongly affect the CYP3A4 enzyme system may increase or decrease Ambrisentan levels, potentially altering its effectiveness or safety. Always check the specific medication’s packaging for exact interaction details.
Storing the tablets away from moisture and heat helps keep them stable during treatment. The length of therapy varies; some patients may use Ambrisentan for many years, while others switch based on response. Different Letairis formulations may have slight differences in dosage strength. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of Ambrisentan and is not medical advice. Medicines containing this ingredient, such as Letairis, may differ in formulation, strength, and directions. The information presented does not replace professional guidance, and liability for any clinical application is disclaimed. Readers should review the labeling of their specific medication and seek guidance from a healthcare professional for personal health decisions.
For more details, you can consult the following resources:
